LEADER 02923nam 2200337 450 001 9910687975003321 005 20230625194821.0 035 $a(CKB)5410000000364665 035 $a(NjHacI)995410000000364665 035 $a(EXLCZ)995410000000364665 100 $a20230625d2020 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aEmbolic Disease $eevolving diagnostic and management approaches /$fedited by Stanislaw P. Stawicki 210 1$aLondon :$cIntechOpen,$d2020. 215 $a1 online resource (176 pages) 311 $a1-78985-330-3 330 $aIn the realm of medical practice, the word "embolism" has many implications to many people, with most providers instinctively placing this word within an inherently negative context. Derived from the Greek word, ????????????, this term most literally means "interposition." Yet, regardless of how benign this etymological derivation may appear, the clinical context is quite the opposite-a symbol of much dreaded morbidity and mortality. Whether the embolus consists of a blood clot, a fat globule, a bubble of gas, amniotic fluid, or even an iatrogenic or traumatic foreign body, the unfavorable connotations persist even if the patient has few or no associated symptoms and requires no intervention.The primary goal of this book is to provide the reader with an overview of the most common types of embolic phenomena encountered in clinical practice, including some of the key related diagnostic and therapeutic considerations. Among chapters featured in the current collection are important contributions in the areas of pulmonary embolism, fat embolism, embolic complications of non-malignant cardiac tumors, acute arterial embolism of the lower extremity, thrombophilia in pregnancy, bullet and shrapnel embolization, coronary artery embolization, as well as a comprehensive review of venous interventions utilized in the management of thromboembolic disorders. When measured in terms of both human and financial costs, broadly defined "embolic phenomena" have tremendous impact on healthcare systems and societies around the globe. Through this academic effort of both our editorial team and individual chapter authors, we hope to provide the reader with valuable insight into the gravity of the collective problem. Among key takeaway messages of this book is that diagnostic relativity and uncertainty continue to prevail in the realm of "embolic diseases." Consequently, much more progress is required before we are able to declare success. 606 $aTherapeutic embolization 615 0$aTherapeutic embolization. 676 $a617.05 702 $aStawicki$b Stanislaw P. 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910687975003321 996 $aEmbolic disease$92959801 997 $aUNINA